1. Home
  2. NEXA vs COLL Comparison

NEXA vs COLL Comparison

Compare NEXA & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$8.90

Market Cap

1.0B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$48.85

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
COLL
Founded
1956
2002
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.5B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
NEXA
COLL
Price
$8.90
$48.85
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$6.20
$47.50
AVG Volume (30 Days)
513.3K
567.1K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
1.15%
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$2,839,970,000.00
$757,067,000.00
Revenue This Year
$3.85
$26.35
Revenue Next Year
$1.53
$3.67
P/E Ratio
N/A
$30.05
Revenue Growth
6.95
26.34
52 Week Low
$4.44
$23.23
52 Week High
$9.61
$49.92

Technical Indicators

Market Signals
Indicator
NEXA
COLL
Relative Strength Index (RSI) 77.88 65.85
Support Level $7.60 $48.29
Resistance Level $8.00 $49.92
Average True Range (ATR) 0.40 1.29
MACD 0.08 -0.29
Stochastic Oscillator 89.76 69.63

Price Performance

Historical Comparison
NEXA
COLL

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: